← Open Payments lookup

MICHELLE MCCLOSKEY: Open Payments

NPI 1598010605 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$907 in 15 payments from 9 companies in 2025. Trend: 2023 $2,160 · 2024 $1,451 · 2025 $907

Food & beverage: $907
CompanyPaymentsAmount
Dexcom, Inc.1$163
SI-BONE, INC.1$130
Edwards Lifesciences Corporation1$125
AstraZeneca Pharmaceuticals LP1$125
Madrigal Pharmaceuticals1$123
Globus Medical, Inc.4$87
Boston Scientific Corporation3$83
Eisai Inc.2$42
Averitas Pharma Inc.1$27

Products named: DEXCOM G7 GSS (161), REZDIFFRA, Senza, Intracept, Lenvima, Intracept RF Probe, QUTENZA, OMNIA.

Industry payments across LA — which companies pay providers there.